Reference
Simon MS, et al. Cost-effectiveness of ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae bacteremia and pneumonia. Antimicrobial Agents and Chemotherapy : 23 Sep 2019. Available from: URL: http://doi.org/10.1128/AAC.00897-19
Rights and permissions
About this article
Cite this article
Ceftazidime/avibactam against drug-resistant Enterobacteriaceae. PharmacoEcon Outcomes News 838, 4 (2019). https://doi.org/10.1007/s40274-019-6249-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6249-z